What is HUMA's gross margin?

Humacyte (HUMA) has a gross margin of -312% and a net margin of -3559%.

What is HUMA's P/E ratio?

Track Humacyte (HUMA) P/E ratio, ROE, and valuation metrics over time.

Where can I see HUMA's full financials?

See Humacyte (HUMA) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Humacyte (HUMA) Financials — Revenue, Earnings, Cash Flow

Also trades as: HUMAW (NASDAQ) · $vol 0M

$1.39

+0.01 (+0.72%)

Pre-Market: $1.36 (-0.03, -2.16%)

Weekly Expected Move ±20.7%

$1 $1 $1 $2 $2

NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Buy · Power 64 · $233.5M mcap · 138M float · 5.41% daily turnover · Short 44% of daily vol

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

📊 Key Metrics

TTM

$2M

Revenue

-74.0% YoY

$-98M

Net Income

-25.7% YoY

$-102M

Free Cash Flow

-1.6% YoY

-311.7%

Gross Margin

-5845.5%

Op. Margin

-3559.4%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE393.8%

ROA-76.8%

ROIC-515.4%

Valuation

P/E-2.8

P/B23.7

EV/EBITDA-1.3

Leverage

Debt/Equity20.86

Current Ratio3.69

Interest Cov.-10.4x

Quality Scores

Piotroski F1/9

Altman Z-10.70

Beneish M-2.87